ScholarIQanswers from OpenAlex
Klinikum Ludwigsburg
InstitutionResearch output, impact & collaborations
Klinikum Ludwigsburg is a institution indexed in ScholarIQ from OpenAlex.
What is known about Klinikum Ludwigsburg?
ScholarIQrecord summary
Klinikum Ludwigsburg is a research organisation in Ludwigsburg, DE. OpenAlex records 1,603 works and 50,916 citations for it. 429 researchers list it as their most recent affiliation.
How many works does Klinikum Ludwigsburg have?
ScholarIQindexed works
Klinikum Ludwigsburg has 1,603 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Klinikum Ludwigsburg have?
ScholarIQcitation count
Klinikum Ludwigsburg has 50,916 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Klinikum Ludwigsburg?
ScholarIQresearcher count
Klinikum Ludwigsburg has 429 researchers in the ScholarIQ index.
What is the average h-index at Klinikum Ludwigsburg?
ScholarIQavg h-index
Klinikum Ludwigsburg has an average h-index of 54.5 in OpenAlex.
What is the ROR of Klinikum Ludwigsburg?
ScholarIQror
The ROR for Klinikum Ludwigsburg is on the source record.
What is the OpenAlex record for Klinikum Ludwigsburg?
ScholarIQopenalex
The OpenAlex for Klinikum Ludwigsburg is on the source record.
Who are the most-cited researchers behind Klinikum Ludwigsburg?
ScholarIQtop researchers by citations
What are the most-cited papers on Klinikum Ludwigsburg?
ScholarIQmost cited works
Early Use of TIPS in Patients with Cirrhosis and Variceal Bleeding
Juan Carlos García‐Pagán, Karel Caca, Christophe Bureau, Wim Laleman, Beate Appenrodt, Angelo Luca, Juan G. Abraldeṣ, Frederik Nevens, Jean Pierre Vinel, Joachim Mössner, Jaime Bosch
Diagnosis and phenotypic classification of Wilson disease<sup>1</sup>
Péter Ferenci, Karel Caca, Georgios Loudianos, Giorgina Mieli‐Vergani, Stuart Tanner, Irmin Sternlieb, Michael L. Schilsky, Diane W. Cox, Frieder Berr
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
Salah‐Eddin Al‐Batran, Ralf‐Dieter Hofheinz, Claudia Pauligk, Hans‐Georg Kopp, Georg Martin Haag, Kim Barbara Luley, Johannes Meiler, Nils Homann, Sylvie Lorenzen, Harald Schmalenberg, Stephan Probst, Michael Koenigsmann, Matthias Egger, Nicole Prasnikar, Karel Caca, Jörg Trojan, Uwe M. Martens, Andreas Block, Wolfgang Fischbach, Rolf Mahlberg, Michael Clemens, Gerald Illerhaus, Katja Zirlik, Dirk Behringer, Wolff Schmiegel, Michael Pohl, Michael Heike, Ulrich Ronellenfitsch, Martin Schüler, Wolf O. Bechstein, Alfred Königsrainer, Timo Gaiser, Peter Schirmacher, Wael Hozaeel, Alexander Reichart, Thorsten Oliver Goetze, Mark Sievert, Elke Jäger, Stefan Mönig, Andrea Tannapfel
Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study
Marianne Ortner, Karel Caca, Frieder Berr, J Liebetruth, Ulrich Mansmann, Dominik Hüster, Winfried A. Voderholzer, Guido Schachschal, Joachim Mössner, Herbert Lochs
Colonoscopic full-thickness resection using an over-the-scope device: a prospective multicentre study in various indications
Arthur Schmidt, Torsten Beyna, Brigitte Schumacher, Alexander Meining, Hans-Juergen Richter-Schrag, Helmut Messmann, Horst Neuhaus, David Albers, Michael Birk, Robert Thimme, Andreas Probst, Martin Faehndrich, Thomas Frieling, Martin Goetz, Bettina Riecken, Karel Caca
How much of the research on Klinikum Ludwigsburg is open access?
ScholarIQopen access share
45%OPEN ACCESS